DOSSIER · 13F-HR · Q2 2026

Troluce Capital Advisors LLC

$971M in tracked AUM across 26 positions as of Q2 2026.

TC
CIK 0001910321 · last filed Jun 30, 2026
Total AUM
$971M
as of Q2 2026
Holdings
26
positions
Whale Score
76
76
strong
Activity
no data
changes this Q
AI Analysis · Q2 2026
Comprehensive Analysis of Troluce Capital Advisors LLC SEC 13F Filing
1. Portfolio Overview

Troluce Capital Advisors LLC manages a concentrated portfolio valued at approximately $431.11 million as of the report date September 30, 2025. The portfolio consists of only 21 holdings, indicating a strategy focused on high conviction rather than broad diversification. The firm experienced modest growth of 2.0% over the quarter, increasing the portfolio value from $422.53 million.

The portfolio s...

2. Key Holdings

The largest position is the SPDR S&P 500 ETF (SPY), comprising 23.18% of the portfolio ($99.93M). Notably, this position was increased by 200% during the quarter, suggesting the manager is using ETF exposure as a liquidity buffer or a core "beta" anchor while reallocating capital around it.

The second-largest holding is Kenvue Inc (KVUE) at 18.16% ($78.31M). This stake was aggressively increased by 359.5%, adding over $56 million. This massive accumulation indicates a strong bullish outlook on the consumer healthcare and consumer defensive giant, likely viewing it as undervalued or a stable cash-flow generator.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
IWM
ISHARES TR
$300M1.0M30.9%
02
SPCX
SPACE EXPLORATION TECHN CORP
$167M975K17.2%
03
SATS
ECHOSTAR CORP
$141M1.4M14.6%
04
AMTM
AMENTUM HOLDINGS INC
$74M3.6M7.6%
05
GSAT
GLOBALSTAR INC
$60M735K6.2%
06
MLYS
MINERALYS THERAPEUTICS INC
$48M1.8M4.9%
07
XBI
SPDR SERIES TRUST
$40M250K4.1%
08
MIR
MIRION TECHNOLOGIES INC
$28M1.5M2.8%
09
AEIS
ADVANCED ENERGY INDS
$24M65K2.5%
10
STOK
STOKE THERAPEUTICS INC
$16M496K1.7%

Filing history

2026Q2Jun 30
$971M 40.5%
26 positionsView →
2026Q1Mar 31
$1.6B 934.6%
70 positionsView →
2025Q4Dec 31
$158M 63.4%
11 positionsView →
2025Q3Sep 30
$431M 2.0%
21 positionsView →
2025Q2Jun 30
$423M 63.3%
30 positionsLocked
2025Q1Mar 31
$259M 91.0%
24 positionsLocked
2024Q4Dec 31
$2.9B 68.7%
34 positionsLocked
2024Q3Sep 30
$1.7B 66.6%
84 positionsLocked
2024Q2Jun 30
$1.0B 23.4%
73 positionsLocked
2024Q1Mar 31
$827M 126.1%
83 positionsLocked
2023Q4Dec 31
$366M 37.5%
35 positionsLocked
2023Q3Sep 30
$266M 87.3%
40 positionsLocked
Showing 12 of 16